Joseph E. Wedekind*1,
Richard Gillilan2, Alena
Janda1, Jolanta Krucinska1,
Jason D. Salter1, Ryan P.
Bennett1, Jay Raina3,
and Harold C. Smith1
1Department of Biochemistry &
Biophysics, University of Rochester School of Medicine and Dentistry,
Rochester, New York 14642
2Macromolecular
Structure Facility at the Cornell High Energy Synchrotron Source
(MacCHESS), Cornell University, Ithaca, NY 14853
3Immunodiagnostics Inc., Woburn, MA
01801
*correspondence to:
joseph.wedekind@rochester.edu
Abstract:
Human APOBEC3G (hA3G) is an innate
deoxycytidine-to-deoxyuridine deaminase that restricts HIV-1 infectivity
by introducing catastrophic mutations into the viral genome in the
absence of the HIV-1 factor vif. hA3G from HIV-permissive, activated
CD4+ T-cells exists as an inactive, high-molecular-mass (HMM) complex
that can be transformed in vitro into an enzymatically active,
low-molecular-mass (LMM) variant comparable to that identified in
HIV-non-permissive CD4+ T-cells. Similarly, hA3G has been detected in
viral capsids as an inactivated ribonucleoprotein whose activity
restoration depends upon the RNase H function of reverse transcriptase.
Collectively, these data support a model that suggests inactivation of
hA3G depends on RNA. To elucidate how RNA influences the structural
organization of hA3G, we determined low resolution structures of
recombinantly expressed HMM- and LMM-variants by small angle X-ray
scattering. The results indicated that LMM particles have an extended
shape, dissimilar to known cytidine deaminase crystal structures.
Structure-based biochemical experiments corroborated these observations
and suggested that each LMM particle comprises a tail-to-tail dimer of
identical subunits. Additional studies indicated that recombinant
LMM-hA3G binds with avidity to nucleic acids and that this interaction
blocks hA3G deamination. Shape analysis of LMM- and HMM-particles led
us to propose a hierarchical assembly model whereby symmetric
association of LMM dimers produces inactive HMM aggregates. These
observations imply that the disruption of cellular HMM species will
require regulation of protein-RNA, as well as protein-protein
interactions, which has implications for therapeutic development.
abstract (pdf)
2008 Run
Nov 19th - Dec 22nd